Bayer Shares Post Hoc Analysis of Lynkuet Sleep Outcomes

Bayer shared a post hoc analysis of self-reported sleep-related outcomes with Lynkuet (elinzanetant) in women with moderate to severe vasomotor symptoms at The Menopause Society Annual Meeting.